Current Clinical Trials

Department: Oncology
Diagnosis: Genito-urinary - Miscellaneous
Principal Investigator: Lash MD, Bradley
Sponsor: CALGB
Indentifier #: NCT00942331
Title: CALGB-90601 A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, And Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458574
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS
Department: Cardiology
Diagnosis: Cardiac - Arrhythmia
Principal Investigator: Deshmukh MD, Pramod
Sponsor: St. Jude Medical
Indentifier #: NCT01507987
Title: "St. Jude Medical Cardiac Lead Assessment Study"
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01470612
Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
Sponsor: Pfizer
Indentifier #: NCT01968967
Title: B1481020, A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of PF-04950615 Following Subcutaneous Dosing for 52 Weeks in Subjects with Primary Hypercholesterolemia or Mixed Dyslipidemia, at High and Very High risk of Cardiovascular Events, Not Controlled with Lipid Lowering Therapy